norethindrone has been researched along with buserelin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, U; Hamilton, M; Irvine, S; Templeton, A | 1 |
| Kuhl, H; Pietzsch, V | 1 |
| Gambone, JC; Judd, HL; Lu, JK; Surrey, ES | 1 |
| Caccamo, A; Cavioni, V; Cristiani, C; Crosignani, PG; Dalprà , L; de Lauretis, L; Lombroso, GC; Ragni, G; Scarduelli, C; Wyssling, H | 2 |
| Belaisch-Allart, J; Forman, R; Frydman, R; Gazengel, A; Hazout, A; Strubb, N; Testart, J | 1 |
| Hoffmann, G; Pollow, K; Schommer, M; von der Ohe, M | 1 |
| Nillius, SJ | 1 |
| Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M | 1 |
| Gold, E; Goulding, A; Stapley, S | 1 |
| Gold, E; Goulding, A | 1 |
| Chryssikopoulos, A; Kontoravdis, A; Phocas, I; Rizos, D | 1 |
| Bekir, J; Engmann, L; Maconochie, N; Tan, SL | 1 |
1 review(s) available for norethindrone and buserelin
| Article | Year |
|---|---|
Gonadotrophin-releasing hormone agonists for new approaches to contraception in man.
Topics: Abortion, Induced; Administration, Intranasal; Breast Neoplasms; Buserelin; Contraception; Corpus Luteum; Erectile Dysfunction; Female; Hormones; Humans; Male; Norethindrone; Oligospermia; Ovulation; Pituitary Hormone-Releasing Hormones; Risk; Testosterone | 1985 |
3 trial(s) available for norethindrone and buserelin
| Article | Year |
|---|---|
Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Luteinizing Hormone; Norethindrone; Ovulation Induction; Pregnancy; Prospective Studies | 1992 |
LHRH agonist and contraception.
Topics: Adolescent; Adult; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Progesterone | 1986 |
Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study.
Topics: Adolescent; Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Humans; Norethindrone; Ovarian Cysts; Ovulation Induction; Pregnancy; Progesterone Congeners; Prospective Studies | 1999 |
9 other study(ies) available for norethindrone and buserelin
| Article | Year |
|---|---|
[Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Protein Binding; Testosterone | 1991 |
The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis.
Topics: Adult; Buserelin; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norethindrone; Self Administration | 1990 |
IVF: induction of ovulation in poor responders.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Female; Fertilization in Vitro; Humans; Menstrual Cycle; Norethindrone; Oocytes; Ovulation Induction | 1989 |
Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability.
Topics: Adult; Buserelin; Clomiphene; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Norethindrone; Oocytes; Ovulation Induction; Triptorelin Pamoate | 1989 |
Ovarian stimulation of IVF patients: effects of the reversible hypogonadotrophic state induced by GnRH agonist.
Topics: Adult; Buserelin; Clomiphene; Drug Therapy, Combination; Female; Fertilization in Vitro; Humans; Menotropins; Menstrual Cycle; Norethindrone; Ovulation Induction | 1988 |
[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Topics: Adult; Buserelin; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Evaluation; Endometrium; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Menstruation; Norethindrone; Norethindrone Acetate; Ovulation; Patient Acceptance of Health Care; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1982 |
Tamoxifen and norethisterone: effects on plasma cholesterol and total body calcium content in the estrogen-deficient rat.
Topics: Animals; Bone Diseases, Metabolic; Buserelin; Calcium; Cholesterol; Estradiol; Estrogens; Female; Norethindrone; Rats; Tamoxifen | 1994 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |
Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception.
Topics: Administration, Intranasal; Adult; Buserelin; Contraception; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Contraindications; Drug Administration Schedule; Drug Costs; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Menstrual Cycle; Norethindrone; Ovary; Progesterone Congeners; Ultrasonography | 1997 |